Acasă › Cancer de sân › Pennsylvania › Philadelphia
Studii clinice pentru Cancer de sân în Philadelphia, PA
56 studii pentru Cancer de sân caută participanți în și în jurul orașului Philadelphia (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
În curs de recrutareFaza 3
- Consultants In Med Onco And Hema, Drexel Hill · La 7 mi distanță
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · La 22 mi distanță
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
În curs de recrutareFaza 2
- University of Pennsylvania, Abramson Cancer Center, Perelman Center for Advanced Medicine, Philadelphia
- Alliance Cancer Specialists, Horsham · La 16 mi distanță
Study of AVZO-021 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
În curs de recrutareFaza 3
- Thomas Jefferson University - Clinical Research Institute ( Site 0056), Philadelphia
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
În curs de recrutareFaza 3
- Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
- Penn Medicine - Chester County Hospital, West Chester · La 24 mi distanță
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
În curs de recrutareFaza 3
- Clinical Trial Site, Horsham · La 16 mi distanță
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
În curs de recrutareFaza 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
În curs de recrutareFaza 3
- University of Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University - Clinical Research Institute, Philadelphia
- Jefferson Hospital Northeast, Philadelphia
- și încă 1
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
În curs de recrutareFaza 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
În curs de recrutareFaza 3
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · La 7 mi distanță
- Consultants In Medical Oncology and Hematology, P.C., Broomall · La 10 mi distanță
- și încă 1
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
În curs de recrutareFaza 1/2
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
În curs de recrutareFaza 1/2
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
În curs de recrutareStudiu observațional
- Abramson Cancer Center, Philadelphia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
În curs de recrutareFaza 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- și încă 11
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
În curs de recrutare
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
ATEMPT 2.0: Adjuvant T-DM1 vs TH
În curs de recrutareFaza 2
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia
În curs de recrutare
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
În curs de recrutareFaza 2/3
- Abramson Cancer Center of The University of Pennsylvania, Philadelphia
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
În curs de recrutare
- Fox Chase Cancer Center, Philadelphia
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
În curs de recrutareFaza 3
- Sidney Kimmel Comprehensive Cancer Center - Thomas Jefferson University Hospital, Philadelphia
E-Mindfulness Approaches for Living After Breast Cancer
În curs de recrutareFaza 3
- UPMC Hillman Cancer Center - Part of Frick Hospital, Mount Pleasant · La 8 mi distanță
- Chester County Hospital, West Chester · La 24 mi distanță
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
În curs de recrutareVoluntari sănătoși bineveniți
- Thomas Jefferson University Hospital, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
În curs de recrutareFaza 2
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1
- Investigative Site #109, Philadelphia
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
În curs de recrutareFaza 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
În curs de recrutare
- Abamson Cancer Center of the University of Pennsylvania, Philadelphia
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
În curs de recrutareFaza 2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
În curs de recrutareFaza 3
- Rittenhouse Hematology/Oncology, Philadelphia
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Hospital of the University of Pennsylvania, Philadelphia
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
În curs de recrutareFaza 2
- University of Pennsylvania (U Penn), Philadelphia
Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
În curs de recrutareFaza 1 timpurie
- Hospital of the University of Pennsylvania, Philadelphia
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
În curs de recrutareFaza 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
În curs de recrutareFaza 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
B.Brilliant Revelation Comparision Study
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Pennsylvania Hospital, Center for Breast Imaging, Philadelphia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
În curs de recrutareFaza 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- și încă 4
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
În curs de recrutareFaza 1
- University of Pennsylvania, Philadelphia
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
În curs de recrutareFaza 2
- University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
În curs de recrutareFaza 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
În curs de recrutareStudiu observațional
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
FES BPET-DBT in Newly Diagnosed Breast Cancer
În curs de recrutareFaza 1 timpurie
- University of Pennsylvania, Philadelphia
Safe and Explainable AI
În curs de recrutareStudiu observațional
- Hospital of the University of Pennsylvania, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
În curs de recrutareFaza 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
CTNNA1 Familial Expansion Study
În curs de recrutareStudiu observațional
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
În curs de recrutareFaza 4
- Albert Einstein Healthcare Network, Philadelphia
[18F] F-GLN by PET/CT in Breast Cancer
În curs de recrutareFaza 1
- University of Pennsylvania, Philadelphia
Prospective Breast Cancer Biospecimen Collection
În curs de recrutareStudiu observațional
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
În curs de recrutare
- University of Pennsylvania, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Philadelphia
Surviving Daily Life
În curs de recrutareStudiu observațional
- Thomas Jefferson University, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
În curs de recrutareFaza 3
- University of Pennsylvania, Philadelphia
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
În curs de recrutareStudiu observațional
- Consultants in Medical Oncology and Hematology, P.C., Broomall · La 10 mi distanță
- Alliance Cancer Specialists, Horsham · La 16 mi distanță
Role of the Immune Environment in Response to Therapy in Breast Cancer
În curs de recrutareStudiu observațional
- Abramson Cancer Center, Philadelphia
Studii pentru Cancer de sân în alte orașe
- New York City, NY136 studii
- Houston, TX126 studii
- Boston, MA112 studii
- Nashville, TN81 studii
- Los Angeles, CA73 studii
- Edison, NJ68 studii
- St. Louis, MO64 studii
- Queens, NY64 studii
- Durham, NC64 studii
- Chicago, IL59 studii
- Dallas, TX55 studii
- Arlington, VA47 studii
Alte studii în Philadelphia
- Cancer (toate tipurile)59 studii
- Cancer pulmonar cu celule non-pătrate51 studii
- Cancer metastatic46 studii
- Cancer de prostată44 studii
- Cancer colorectal44 studii
- Cancer ovarian44 studii
- Cancer pulmonar36 studii
- Leucemie mieloasă acută34 studii
- Insuficiență cardiacă31 studii
- Cancer endometrial28 studii
- Depresie26 studii
- Cancer pancreatic26 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.